Joshi Avni Y, Iyer Vivek N, St Sauver Jennifer L, Jacobson Robert M, Boyce Thomas G
Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN, United States.
Vaccine. 2009 Jul 16;27(33):4457-61. doi: 10.1016/j.vaccine.2009.05.038. Epub 2009 May 31.
The effectiveness of influenza vaccine over multiple influenza seasons in children less than 5 years of age has not been well studied. This is especially important to assess because of the recent recommendation for routine influenza vaccination in childhood. We conducted a matched case-control study to assess the vaccine effectiveness of Trivalent Inactivated Influenza Vaccine (TIV) against laboratory-confirmed, medically attended influenza among children 6-59 months of age at the start of each influenza season from 1999-2000 through 2006-2007 in Olmsted County, MN, USA. The children vaccinated against influenza accordingly to the 2007 ACIP guidelines had a lower risk of laboratory-confirmed medically attended influenza illness (Odds Ratio: 0.14, 95% Confidence Interval: 0.03-0.71) than the unvaccinated children. TIV provided strong protection against laboratory-confirmed medically attended influenza in children 6-59 months old in the fully vaccinated group. This trend continued in the partially vaccinated group (Odds Ratio: 0.27, 95% Confidence Interval: 0.07-0.97) but the protection provided maybe suboptimal.
在5岁以下儿童中,流感疫苗在多个流感季节的有效性尚未得到充分研究。鉴于最近关于儿童常规接种流感疫苗的建议,评估这一点尤为重要。我们进行了一项匹配病例对照研究,以评估1999 - 2000年至2006 - 2007年美国明尼苏达州奥尔姆斯特德县每个流感季节开始时,6至59个月大儿童接种三价灭活流感疫苗(TIV)预防实验室确诊且就医的流感的疫苗有效性。根据2007年美国免疫实践咨询委员会(ACIP)指南接种流感疫苗的儿童,与未接种疫苗的儿童相比,实验室确诊且就医的流感疾病风险更低(比值比:0.14,95%置信区间:0.03 - 0.71)。在完全接种疫苗的组中,TIV为6至59个月大的儿童提供了强有力的保护,预防实验室确诊且就医的流感。这种趋势在部分接种疫苗的组中也持续存在(比值比:0.27,95%置信区间:0.07 - 0.97),但提供的保护可能并非最佳。